Intellia Therapeutics Inc (NTLA)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$9.56
Buy
$9.65
$0.26 (+2.83%)
Intellia Therapeutics Inc is a gene editing company focused on the development of proprietary, potentially curative therapeutics utilizing a biological tool known as the CRISPR/Cas9 system.
Prices updated at 22 May 2025, 11:22 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
$9.57 - $9.02 | |
$28.18 - $5.90 | |
- | |
979.90m | |
- | |
- | |
3,564 | |
1.26 | |
2,545,936.19 | |
1.82 | |
102.03m | |
US45826J1051 | |
-5.23 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.